HANGZHOU HUAYU BIOPHARMA CO., LTDwww.huayuubio.com
|

Octreotide Acetate

Octreotide Acetate (Sandostatin) is a synthetic somatostatin analogue used to treat metastatic carcinoid tumors, VIP-secretory tumors, and acromegaly. It selectively inhibits growth hormone, glucagon, and insulin secretion with longer-lasting effects than natural somatostatin.

Octreotide Acetate
CAS No.79517-01-4
M.FC49H66N10O10S2 · C2H4O2
M.W1080.29
Send Inquiry
Contact Us

Description

Product Introduction

Octreotide belongs to digestive system drugs, which is an artificially synthetic cyclic octapeptide compound, and is a homolog of natural somatostatin. It contains the pharmacological activity of a natural somatostatin, and has long-lasting effects (the half-lifetime of this product is 1.5 hours, while it is 2 to 3 minutes for natural somatostatin). The product selectively inhibits the secretion of growth hormone, glucagon and insulin, and the effect is stronger than natural.

Application

Octreotide acetate (Sandostatin) is used to treat metastatic carcinoid tumors, vasoactive intestinal peptide-secretory tumors, also used in treatment of acromegaly. Octreotide (Sandostatin) is a synthetic somatostatin analogue; it can be produced by two methods: fragment condensation solution phase procedures and solid-phase procedures.

Product Description

Application Field
Endocrine therapy, acromegaly, neuroendocrine tumors, peptide drug API
Packaging
Custom packaging per client requirements
Storage Conditions
-20°C, protected from light, sealed storage
Shelf Life
2 years

Specifications

AppearanceWhite to off-white powder
Purity (HPLC)≥98%

Hot Tags

OctreotideSomatostatinAcromegalyNeuroendocrine TumorsPeptide

You Might Also Like